google_counter
background_img

University Hospital Bonn

location_on Bonn, Germany
9.2/10 from 150 Votes

Department of Nuclear Medicine (279215)

Markus Essler

Prof. Dr. med.

Markus Essler

Specialized in: nuclear medicine

The Department of Nuclear Medicine at the University Hospital Bonn provides all kinds of diagnostic and therapeutic procedures involving the use of radiopharmaceuticals. The Department of Nuclear Medicine is one of few institutions in the world, where is provided the full range of therapeutic interventions with the use of the most advanced methods. The head of the Department is Prof. Dr. med. Markus Essler. 

Since October 2014 the Department of Nuclear Medicine at the University Hospital Bonn has implemented a new effective method for prostate cancer treatment and now uses it quite often. 177Lu-PSMA therapy is a unique opportunity enabling a targeted specialized medical care for prostate cancer patients in case if they are not responsive to hormone and chemotherapy. In contrast to a recently implemented radium-223 treatment method for bone metastases, the patients with metastases in loco-regional lymph nodes or organ metastases have an opportunity to by treated by 177Lu-PSMA. 

The main objective of the Department is diagnosis and treatment of thyroid diseases. A competent team of doctors under the direction of Prof. Dr. med. Markus Essler is at Your disposal in the outpatient clinic at the university and Medical Center Venusberg. Radioiodine therapy is carried out in the internal medicine unit. The Department maintains a close cooperation with the Department of Surgery, Department of Internal Medicine I and III at the University Hospital Bonn as well as with numerous private practitioners. 

The range of clinical services of the Department of Nuclear Medicine at the University Hospital Bonn includes:

  • Thyroid diseases:
    • Hot thyroid nodule (thyroid autonomy)
    • Grave’s disease
    • Autoimmune thyroiditis (Hashimoto thyroiditis)
    • Subacute thyroiditis
    • Amiodarone-induced hypothyroidism
    • Thyroid cancer
    • Enlarged thyroid
    • Thyroid function disorder during pregnancy (in cooperation with the Department of Reproductive Medicine)
  • Heart diseases
  • Lung cancer
  • Breast cancer
  • Prostate cancer
  • Neuroendocrine tumors
  • Selective internal radiation therapy SIRT for liver metastases and liver cancer
  • 18F-FDG-PET/CT method for malignant melanoma (black skin cancer)
  • Brain tumors (glioma and glioblastoma)

There are provided the following modern therapy methods:

  • I-131 radioiodine therapy for benign diseases (functional thyroid autonomy, Grave’s disease, thyroid size reduction)
  • I-131 radioiodine therapy for malignant diseases (thyroid cancer)
  • Peptide receptor radionuclide therapy (PRRT) by 177Lu-DOTATE for neuroendocrine tumors
  • Selective internal radiation therapy SIRT / yttrium-90 (Y-90) radioembolization 
  • Lu-177 PSMA therapy for metastazing prostate cancer with a hormonal refractivity
  • Treatment of prostate cancer bone metastases by Ra-223
  • Radio synovectomy (RSO)
  • Yttrium Y-90 Ibritumomab-tiuxetan radioimmunotherapy 
  • I-131-MIBG radionuclide therapy
  • Yttrium-90 (Y-90) radiopleurodesis 

Save up to 50%

With Booking Health you will save up to 50% of the cost

Thank you!

We received your treatment application in the best Europe clinics. Our manager will contact you within the next 24 hours.